| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 03/09/2006 | WO2006024628A1 Tricyclic lactam derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 03/09/2006 | WO2005097792A8 Device and method for pneumatic valve control |
| 03/09/2006 | WO2005094531A3 Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines |
| 03/09/2006 | WO2005058841A3 Hiv protease inhibiting compounds |
| 03/09/2006 | WO2005014572A8 Pyrimidylpyrrole derivatives active as kinase inhibitors |
| 03/09/2006 | WO2004106335A8 Harmine derivatives, intermediates used in their preparation, preparation processes and use thereof |
| 03/09/2006 | US20060052595 Heterocyclic compounds as ccr5 antagonists |
| 03/09/2006 | US20060052412 2-(2-oxa-3-azabicyclo[2.2.2]oct-5-en-3-yl)-6-amino-9-methyl-1-deazapurine; antiinflammatory, neuroleptic agent, antiallergens, neuroprotectant and antidepressant, cognition activator; improved bioavailability, without a ribose moiety; prodrugs with primary or secondary amino or hydroxy groups |
| 03/09/2006 | US20060052411 Immunosuppressants, analgesics, antiinflammatory agents |
| 03/09/2006 | US20060052408 Cyclopropyl compounds as ccr5 antagonists |
| 03/09/2006 | US20060052407 crystal of a non-solvate of (3R)-1-butyl-2,5-dioxo-3-[(1R)-1-hydroxy-1-cyclohexylmethyl]-9-[4-(4-carboxyphenyloxy)phenylmethyl]-1,4,9-triazaspiro[5.5]undecane hydrochloride; chemokine antagonist |
| 03/09/2006 | US20060052406 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor |
| 03/09/2006 | US20060052398 Novel vitronectin receptor antagonist derivatives, method for preparing same, use thereof as medicines and pharmaceutical compositions containing same |
| 03/09/2006 | US20060052397 Compounds for trearment of cardiovascular disorders and hypotensive agents |
| 03/09/2006 | US20060052388 Amine and amide derivatives as ligands for the neuropeptide Y Y5 receptor useful in the treatment of obesity and other disorders |
| 03/09/2006 | US20060052385 For therapy of neurological disorder |
| 03/09/2006 | US20060052378 Psychological disorders; analgesics; eating disorders; drug abuse; 4-(8-chloro-naphthalen-2-yl)-2-methyl-1,2,3,4-tetrahydroisoquinolin-7-ol; 7-(6-methoxy-pyrazin-2yl)-2-methyl-4-(naphthalene-2-yl)-1,2,3,4-tetrahydroisoquinoline; treating amide intermediates with sodium borohydride |
| 03/09/2006 | US20060052368 Aryl-substituted diazabicycloalkanes as nicotinic acetylcholine agonists |
| 03/09/2006 | US20060052361 Aids therapy; side effect reduction |
| 03/09/2006 | US20060052345 Quinazolinone compounds as calcilytics |
| 03/09/2006 | US20060051811 Site-specific labelling of proteins using acridone and quinacridone lifetime dyes |
| 03/09/2006 | US20060051612 Light-emitting device, condensed polycyclic compound used therein and method for producing same |
| 03/09/2006 | US20060051293 noninvasive technique for imaging and quantitating amyloid deposits; 2-phenyl- imidazo [1,2,a] pyridine derivatives; radiolabelling; drug delivery; 2-(4'-dimethylaminophenyl)-6-iodobenzothiazole |
| 03/09/2006 | CA2583428A1 Bicyclic heteroaryl pde4b inhibitors |
| 03/09/2006 | CA2578880A1 Pyrrolo[3,2-c]pyridine derivatives and processes for the preparation thereof |
| 03/09/2006 | CA2578781A1 Fused tricyclic derivatives for the treatment of psychotic disorders |
| 03/09/2006 | CA2578630A1 Pyrimidinylimidazoles as tgf-beta inhibitors |
| 03/09/2006 | CA2578628A1 Pyrimidinylpyrazoles as tgf-beta inhibitors |
| 03/09/2006 | CA2578604A1 Piperidine derivative or pharmaceutically acceptable salt thereof |
| 03/09/2006 | CA2578391A1 Determination of nucleic acid using electrocatalytic intercalators |
| 03/09/2006 | CA2577947A1 Novel substituted imidazole derivative |
| 03/09/2006 | CA2577275A1 Quinazolinone derivatives and their use as b-raf inhibitors |
| 03/09/2006 | CA2576988A1 Androgen receptor modulators |
| 03/09/2006 | CA2576850A1 Tricyclic lactam derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 03/09/2006 | CA2576782A1 Methods of treatment of amyloidosis using substituted ethanolcyclicamine aspartyl protease inhibitors |
| 03/09/2006 | CA2576765A1 Pyridine methylene azolidinones and use thereof phosphoinositide inhibitors |
| 03/08/2006 | EP1632492A1 Tricyclic compound |
| 03/08/2006 | EP1632488A1 Cyclic tertiary amine compound |
| 03/08/2006 | EP1632483A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands |
| 03/08/2006 | EP1632477A1 Benzamide derivative or salt thereof |
| 03/08/2006 | EP1631571A1 Novel intermediate for the preparation of therapeutically active imidazopyridines |
| 03/08/2006 | EP1631570A1 Naphthyridine derivatives as antibacterial agents |
| 03/08/2006 | EP1631542A1 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof |
| 03/08/2006 | EP1631355A1 Piperidinyl prostaglandin e analogs |
| 03/08/2006 | EP1451167B1 Phenylalkynes |
| 03/08/2006 | EP1445252B1 Sulphonamide derivatives, the preparation thereof and the application of same as medicaments |
| 03/08/2006 | EP1347966B1 Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives |
| 03/08/2006 | EP1343784B1 UREA SUBSTITUTED IMIDAZOQUINOLINE ETHERS and pharmaceutical compositions comprising the same. |
| 03/08/2006 | EP1325009B1 Amino-substituted tetracyclic compounds useful as anti-inflammatory agents and pharmaceutical compositions comprising same |
| 03/08/2006 | EP1318995B1 Pyridinone and pyridinethione derivatives having hiv inhibiting properties |
| 03/08/2006 | EP1313721B1 Non-imidazole aryloxyalkylamines as h3 receptor ligands |
| 03/08/2006 | EP1176959B1 Novel prolines as antimicrobial agents |
| 03/08/2006 | EP1149078B1 Selective 5-ht 6 receptor ligands |
| 03/08/2006 | CN1745082A Solvent-free process for the preparation of diketopyrrolopyrrole derivatives |
| 03/08/2006 | CN1745080A 1,3-dihydroimidazole fused-ring compound |
| 03/08/2006 | CN1745077A 促旋酶抑制剂及其用途 Gyrase inhibitors and their use |
| 03/08/2006 | CN1745076A Malonamide derivatives as gamma-secretase inhibitors |
| 03/08/2006 | CN1745071A Novel ethylenediamine derivatives |
| 03/08/2006 | CN1745070A 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors |
| 03/08/2006 | CN1745064A Pyridines for treating injured mammalian nerve tissue |
| 03/08/2006 | CN1745063A Compound inhibiting dipeptidyl peptidase iv |
| 03/08/2006 | CN1743330A Aspergillus fumigatus dardarin C analogue, and its synthesizing method and use |
| 03/08/2006 | CN1743329A Hexahydro-pyrazino-pyridino-indole dione, and its synthesis and use |
| 03/08/2006 | CN1743328A Hexahydro-pyrazino-pyridino-indole, and its systhesis and use |
| 03/08/2006 | CN1743327A Indole alkaloid derivative, and its preparing method and use |
| 03/08/2006 | CN1743326A Carboline carboxylate derivative, and its synthesizing method and use |
| 03/08/2006 | CN1743312A Fused-polycyclic compounds |
| 03/08/2006 | CN1244582C Compound of quinolone carboxylic acid, preparation method and medicinal usage |
| 03/08/2006 | CN1244576C Chemical compounds |
| 03/08/2006 | CN1244561C Tetrahydroisoquinoline analogs useful as growth hormone secretagogues |
| 03/07/2006 | US7009047 Reacting ethylenediamine with 2-bromo-3-phenylpropyionic acid; salt formation; angiotensin converting enzyme inhibitor |
| 03/07/2006 | US7008948 Fused pyrimidyl pyrazole compounds useful as protein kinase inhibitors |
| 03/07/2006 | US7008947 Use to treat anxiety, depression, a sleep disorder such as primary insomnia, circadian rhythm sleep disorder, dyssomnia NOS, nightmare disorder, or attention deficit disorder |
| 03/07/2006 | US7008753 Optical recording medium |
| 03/07/2006 | US7008616 Ephedrine or fenfluramine; aluminum foil coated with a thin layer of drug is heated to form vapor; which condenses to form aerosol; rapid peak plasma concentration |
| 03/07/2006 | US7008615 Delivery of anti-migraine compounds through an inhalation route |
| 03/07/2006 | US7008568 Photochromic naphthopyran compounds: compositions and articles containing those naphthopyran compounds |
| 03/02/2006 | WO2006023704A2 Lonidamine analogues and their use in male contraception and cancer treatment |
| 03/02/2006 | WO2006022773A1 Gyrase inhibitors and uses thereof |
| 03/02/2006 | WO2006010423A3 Azaindole inhibitors of mtp and apob |
| 03/02/2006 | WO2005123672A3 Kinase inhibitors |
| 03/02/2006 | WO2005113542A3 N-cyclic sulfonamido inhibitors of gamma secretase |
| 03/02/2006 | WO2005101838A3 Piperazinylpiperidine derivatives as chemokine receptor antagonists |
| 03/02/2006 | WO2005092895A3 Alpha aryl or heteroaryl methyl beta piperidino propanoic acid compounds as orl1-receptor antagonists |
| 03/02/2006 | WO2005092858A3 Alpha aryl or heteroaryl methyl beta piperidino propanamide compounds as orl1-receptor antagonist |
| 03/02/2006 | WO2005051293A3 Methods and reagents for the treatment of inflammatory disorders |
| 03/02/2006 | WO2004110364A3 Thiotungstate analogues and uses thereof |
| 03/02/2006 | US20060047126 e.g. 3-[1-(2,4-dichlorobenzyl)-6-trifluoromethyl-1H-indazol-3-yl]-acrylic acid; anticarcinogenic agent; inhibitors of spermatogenesis, heat shock proteins and/or elongation factor 1 alpha; analogues of lonidamine |
| 03/02/2006 | US20060047116 Such as N-methyl(1-{2-[(1R,5S)-3-(2-methyl-1H-benzimidazol-1-yl)-8-azabicyclo[3.2.1]oct-8-yl]ethyl}-2,3-dihydro-1H-inden-1-yl)methanamine; chemokine receptor antagonists; prevention or treatment of a human T-cell leukemia/lymphoma virus infection |
| 03/02/2006 | US20060046995 anti-bacterial agents; staphylococci; coliform bacteria; 7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide; bridged bicyclic ureas or carbamates having bridgehead nitrogen |
| 03/02/2006 | US20060046992 Heterobicyclic compounds |
| 03/02/2006 | US20060046985 Tetrahydro--4h-pyrido[1,2-a}pyrimidines and related compounds useful as hiv integrase inhibitors |
| 03/02/2006 | US20060046254 Determination of nucleic acid using electrocatalytic intercalators |
| 03/02/2006 | DE102004041604A1 Verfahren zur Herstellung von Quaterrylen-3,4:13,14-tetracarbonsäurediimiden durch Direktsynthese A process for preparing quaterrylene-3,4: 13,14-tetracarboxylic diimides by direct synthesis |
| 03/02/2006 | DE102004041163A1 Neue Verbindungen mit antibakterieller Aktivität New compounds with antibacterial activity |
| 03/02/2006 | CA2578122A1 Pyrimidine derivatives |
| 03/02/2006 | CA2578075A1 Aminoheteroaryl compounds as protein tyrosine kinase inhibitors |
| 03/02/2006 | CA2577677A1 Modulators of muscarinic receptors |
| 03/02/2006 | CA2577528A1 Heterocyclic antiviral compounds |
| 03/02/2006 | CA2577084A1 Bicyclononene derivatives as renin inhibitors |